BioSpace News Archive

Physician’s Choice® brings to the table a new take on turmeric supplements with naturally sourced curcuminoids, boswellia, and ginger to relieve joint pain and inflammation

CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets, announced that it has appointed Glenn Hassan to the position of Chief Financial Officer and Chief Business Officer, and Gerald F.

International Hemp Exchange (IHE), a leader in the burgeoning U.S. hemp industry, and Seed2System, are proud to announce production of up to 10 million HGH feminized seed starts available for nationwide delivery this spring out of their Colorado nursery.

With the highest rate of measles cases being reported in the United States since the disease was declared eliminated in 2000, Rite Aid announced today that Measles-Mumps-Rubella (MMR) vaccinations are available upon request at Rite Aid pharmacies across California including Los Angeles County.

Leah Hughes, APRN with Apex Health, Human Performance & Longevity Optimization is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED).

Adrienne Carmack, MD with Integrative Health Matters is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This cutting-edge procedure boasts a 75% success rate amongst patients.

In the preliminary meeting of operating the regional research center, International Centre for Genetic Engineering Biotechnology in China, Science and Technology Daily was informed that China Medical City, China’s leading medical industrialization base in Taizhou, Jiangsu Province, was invited by ICGEB to discuss the promotion and collaboration between CMC and ICGEB.

Colgate-Palmolive Company reported worldwide Net sales of $3,884 million in first quarter 2019, a decrease of 3.0% versus first quarter 2018.

Antibe Therapeutics Inc. is pleased to announce that it will be presenting at the upcoming Bloom Burton & Co. Healthcare Investor Conference being held on Tuesday, April 30 - Wednesday, May 1, 2019 in Toronto, Canada.

Global pharmaceutical company Mylan N.V. announced that it will release its first quarter 2019 financial results on Tues., May 7, before the open of the U.S. financial markets.